The New Standard of mRNA R&D: Creative Biolabs Combines Methylation Assays with saRNA Synthesis

Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
News-Medical.Net

FDA-approved anti-seizure drug could help fight Alzheimer's disease

While physicians and scientists have long known Alzheimer's disease involves the buildup of toxic protein fragments in the ...

Black Mesa awarded ARPA-H funding to develop a ‘Good AI Practice’ (GAIP) framework

Black Mesa announces funding from the Advanced Research Projects Agency for Health (ARPA-H) to develop a Good AI ...
EurekAlert!

Insilico Medicine featured in Harvard Business School case on Rentosertib

CAMBRIDGE, Mass., February 12, 2026 - Insilico Medicine (3696.HK), a clinical-stage, generative AI-driven drug discovery company, today announced the launch of a new interactive webpage highlighting ...

Common anti-seizure drug prevents Alzheimer's plaques from forming, study shows

While physicians and scientists have long known that Alzheimer's disease involves the buildup of toxic protein fragments in ...
Talker

Cheap drug may prevent plaques linked to dementia from forming

Experts have known for some time that Alzheimer’s disease involves the build-up of toxic protein fragments in the brain.
BioSpace

AI Is Changing Pharma’s Bottom Line Now—But Not Through Splashy Drug Discovery

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.

NanoViricides President Dr. Diwan Interviewed by Mission Matters’ Adam Torres

SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
EurekAlert!

AI that understands chemical principles... Accelerating the development of new drugs and materials

Whether a smartphone battery lasts longer or a new drug can be developed to treat incurable diseases depends on how stably the atoms constituting the material are bonded. The core of 'molecular design ...

How AI Is Reshaping Drug Discovery And Healthcare Investing

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Faster enzyme screening could cut biocatalysis bottlenecks in drug development

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

New paper urges caution as FDA plans to phase out animal testing in drug development

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...